Literature DB >> 25005340

Outcomes of pharmacogenetics-guided dosing of warfarin: a systematic review and meta-analysis.

Qinghui Tang1, Houjuan Zou1, Caihong Guo1, Zhengxiang Liu2.   

Abstract

Entities:  

Keywords:  Meta-analysis; Outcome; Pharmacogenetics; Warfarin

Mesh：

Substances：

Year:  2014        PMID： 25005340     DOI： 10.1016/j.ijcard.2014.06.031

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  10 in total

1.  Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials.

Authors:  H L Tang; W L Shi; X G Li; T Zhang; S D Zhai; H G Xie
Journal:  Pharmacogenomics J       Date:  2015-04-14       Impact factor: 3.550

2.  Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Gary Tse; Mengqi Gong; Guangping Li; Sunny Hei Wong; William K K Wu; Wing Tak Wong; Leonardo Roever; Alex Pui Wai Lee; Gregory Y H Lip; Martin C S Wong; Tong Liu
Journal:  Br J Clin Pharmacol       Date:  2018-06-21       Impact factor: 4.335

Review 3.  Precision dosing of warfarin: open questions and strategies.

Authors:  Xi Li; Dan Li; Ji-Chu Wu; Zhao-Qian Liu; Hong-Hao Zhou; Ji-Ye Yin
Journal:  Pharmacogenomics J       Date:  2019-02-12       Impact factor: 3.550

4.  VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients.

Authors:  Silvia Misasi; Giuliana Martini; Oriana Paoletti; Stefano Calza; Giovanni Scovoli; Alessandra Marengoni; Sophie Testa; Luigi Caimi; Eleonora Marchina
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 5.  Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine.

Authors:  Cristina Lucía Dávila-Fajardo; Xando Díaz-Villamarín; Alba Antúnez-Rodríguez; Ana Estefanía Fernández-Gómez; Paloma García-Navas; Luis Javier Martínez-González; José Augusto Dávila-Fajardo; José Cabeza Barrera
Journal:  Genes (Basel)       Date:  2019-04-01       Impact factor: 4.096

6.  Variants in CDHR3, CACNAC1, and LTA Genes Predisposing Sensitivity and Response to Warfarin in Patients with Cardiovascular Disease.

Authors:  Mansour A Alghamdi; Laith Al-Eitan; Rami Alkhatib; Ahmad Al-Assi; Ayah Almasri; Hanan Aljamal; Hatem Aman; Rame Khasawneh
Journal:  Int J Gen Med       Date:  2021-03-25

7.  Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis.

Authors:  Shangqing Jiang; Patrick C Mathias; Nathaniel Hendrix; Brian H Shirts; Peter Tarczy-Hornoch; David Veenstra; Daniel Malone; Beth Devine
Journal:  Pharmacogenomics J       Date:  2022-04-01       Impact factor: 3.245

8.  Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Changcheng Shi; Wei Yan; Gang Wang; Fei Wang; Qingyu Li; Nengming Lin
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

Review 9.  Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.

Authors:  Simran D S Maggo; Ruth L Savage; Martin A Kennedy
Journal:  Clin Pharmacokinet       Date:  2016-04       Impact factor: 6.447

Review 10.  Warfarin dosing algorithms: A systematic review.

Authors:  Innocent G Asiimwe; Eunice J Zhang; Rostam Osanlou; Andrea L Jorgensen; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2020-11-18       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.